|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Tracon Pharmaceuticals, Inc. (TCON) |
|
|
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,680,000 |
Market
Cap: |
3.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1322 - $0.67 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,418,993 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,892,637 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
30 |
Total Shares Sold |
0 |
0 |
4,764,008 |
4,765,667 |
Total Sell Value |
$0 |
$0 |
$1,401,571 |
$1,403,938 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
3 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Theuer Charles |
President and CEO |
|
2022-09-22 |
4 |
B |
$1.76 |
$8,800 |
D/D |
5,000 |
267,518 |
2.81 |
-6% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-09-22 |
4 |
B |
$1.73 |
$29,943 |
I/I |
17,311 |
398,900 |
1.5 |
-6% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-09-20 |
4 |
B |
$1.85 |
$18,524 |
I/I |
10,000 |
385,000 |
1.5 |
-9% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-09-19 |
4 |
B |
$1.87 |
$9,367 |
I/I |
5,000 |
375,000 |
1.5 |
-10% |
|
Brown Scott B. |
Chief Financial Officer |
|
2022-09-12 |
4 |
B |
$2.02 |
$5,038 |
D/D |
2,500 |
14,628 |
2.74 |
-19% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-07-26 |
4 |
B |
$1.72 |
$3,877 |
I/I |
2,254 |
370,000 |
1.42 |
-17% |
|
Theuer Charles |
President and CEO |
|
2022-07-22 |
4 |
B |
$1.85 |
$8,325 |
D/D |
4,500 |
262,518 |
2.81 |
-14% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-07-15 |
4 |
B |
$1.78 |
$21,068 |
I/I |
11,826 |
367,746 |
1.5 |
-16% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-07-14 |
4 |
B |
$1.81 |
$13,024 |
I/I |
7,187 |
355,920 |
1.5 |
-17% |
|
Theuer Charles |
President and CEO |
|
2022-07-13 |
4 |
B |
$1.84 |
$5,520 |
D/D |
3,000 |
258,018 |
2.81 |
-22% |
|
Theuer Charles |
President and CEO |
|
2022-07-12 |
4 |
B |
$1.87 |
$5,610 |
D/D |
3,000 |
255,018 |
2.81 |
-24% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-06-24 |
4 |
B |
$1.39 |
$15,894 |
I/I |
11,419 |
348,733 |
1.5 |
-10% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-06-21 |
4 |
B |
$1.31 |
$1,105,279 |
I/I |
841,989 |
3,776,589 |
1.5 |
14% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-05-10 |
4 |
B |
$1.76 |
$17,032 |
I/I |
9,700 |
337,314 |
1.5 |
3% |
|
Theuer Charles |
President and CEO |
|
2022-05-09 |
4 |
B |
$1.85 |
$18,500 |
D/D |
10,000 |
252,018 |
2.81 |
8% |
|
Theuer Charles |
President and CEO |
|
2022-05-06 |
4 |
B |
$1.97 |
$4,925 |
D/D |
2,500 |
242,018 |
2.73 |
-5% |
|
Theuer Charles |
President and CEO |
|
2022-04-29 |
4 |
B |
$1.97 |
$9,855 |
D/D |
5,000 |
239,518 |
2.81 |
1% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-25 |
4 |
B |
$2.18 |
$23,497 |
I/I |
10,777 |
335,114 |
1.5 |
-10% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-22 |
4 |
B |
$1.98 |
$14,058 |
I/I |
7,100 |
336,114 |
1.5 |
-10% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-22 |
4 |
B |
$2.24 |
$93,941 |
I/I |
42,000 |
334,337 |
1.5 |
-10% |
|
Theuer Charles |
President and CEO |
|
2022-04-21 |
4 |
B |
$2.30 |
$10,350 |
D/D |
4,500 |
234,518 |
2.81 |
-11% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-14 |
4 |
B |
$2.50 |
$31,730 |
I/I |
12,696 |
330,041 |
1.5 |
-16% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-13 |
4 |
B |
$2.50 |
$18,361 |
I/I |
7,345 |
327,345 |
1.5 |
-16% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-12 |
4 |
B |
$2.48 |
$44,827 |
I/I |
18,098 |
325,000 |
1.5 |
-13% |
|
Opaleye Management Inc. |
10% Owner |
|
2022-04-11 |
4 |
B |
$2.42 |
$22,019 |
I/I |
9,100 |
320,000 |
1.5 |
-16% |
|
241 Records found
|
|
Page 2 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|